Crinetics Pharmaceuticals Inc buy Stifel Nicolaus
Start price
25.03.25
/
50%
€31.80
Target price
25.03.26
€55.52
Performance (%)
-6.29%
Price
12.12.25
€43.00
Summary
This prediction is currently active. With a performance of -6.29%, the BUY prediction for Crinetics Pharmaceuticals Inc by Stifel_Nicolaus is down slightly. This prediction currently runs until 25.03.26. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Crinetics Pharmaceuticals Inc | 5.392% | 5.392% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Stifel_Nicolaus for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $60.00 price target on the stock.
Ratings data for CRNX provided by MarketBeat